CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In…
An institutional-grade, numbers-driven thesis on CVS — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 7, 2026, TradersQuant's model rates CVS Health Corp (CVS) 59/100 with a 12-month base-case forecast of $103.54 — +7.6% versus the current price of $96.22. CVS Health Corp trades at $96.22 in the Health Care sector, with a market capitalisation of $122.77B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for CVS is $103.54, implying +7.6% versus the current price. The model's 12-month scenario range runs from $96.44 (bear) to $116.89 (bull), with a base case of $103.54.
On the fundamentals, CVS Health shows a P/E of 42.4, trailing revenue of $406.93B, revenue growth of +7.6% YoY, a dividend yield of 2.76%. This page also tracks CVS's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
CVS currently carries a TradersQuant composite score of 59/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "buy". Our 12-month price target of $103.54 implies +7.6% from $96.22. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for CVS is $103.54, about +7.6% versus the latest price of $96.22. Consensus is based on 33 analysts.
TradersQuant's 12-month model forecast for CVS is a base case of $103.54, ranging from $96.44 (bear) to $116.89 (bull), an expected return of +7.6%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for CVS over the next 12 months is $103.54 in the base case (bear $96.44, bull $116.89), versus today's price of $96.22. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for CVS — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates CVS's fair value at $124.60, implying +29.5% of expected upside versus the current price.
Yes — CVS Health pays a dividend yielding 2.76% (about $2.66 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
